References
- Durk, B.G. and Salmon, S.E. (1975) "A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival", Cancer, 36, 842–854.
- Wisloff, F., Andersen, P., Andersson, T.R., Brandt, E., Eika, C., Fjaestad, K., et al. (1991) "Incidence and follow-up of asymptomatic multiple myeloma. The myeloma project of health region I in Norway. II", European Journal of Haematology, 47, 338–341.
- Dimopoulos, MA., Moulopoulos, A., Smith, T., Delasalle, K.B. and Alexanian, R. (1993) "Risk of disease progression in asymptomatic multiple myeloma", American Journal of Medicine, 94, 57 — 61.
- Facon, T., Menard, J.F., Michaux, J.L., Euller-Ziegler, L., Bernard, J.F., Grosbois, B., et al. (1995) "Prognostic factors in low tumor mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myelome (GERM)", American Journal of Hematology, 48, 71–75.
- Dimopoulos, M.A., Moulopoulos, L.A., Maniatis, A. and Alexanian, R. (2000) "Solitary plasmacytoma of bone and asymptomatic multiple myeloma", Blood, 96, 2037 — 2044.
- Tricot, G., Sawyer, J.R., Jagannath, S., Desikan, KR., Siegel, D., Naucke, S., et al. (1997) "Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and auto-transplants", Journal of Clinical Oncology, 15, 2659–2666.
- Lai, J.L., Zandecici, M., Mary, J.Y., Bernardi, F., Izydorczyk, V., Flactif, M., et al. (1995) "Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis", Blood„ 85, 2490–2497.
- Lokhorst, H.M., Boom, SE., Terpstra, W., Roholl, P., Gerdes, J. and Bast, B.J. (1988) "Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67", British Journal of Haematology, 69, 477 —481.